staff reporter
Articles Authored by staff reporter
LifeBit to Store, Manage Data For Lung Cancer Genetics Study
Non-profit research institutions will be able to access data from the 23andMe-sponsored study via a Lifebit data platform.
BostonGene, BeiGene Collaborate to Discover Biomarkers to Guide Mantle Cell Lymphoma Treatment
The partners will study biomarkers of treatment resistance and response in MCL using BostonGene's AI-driven multiomic platform.
Voyager Therapeutics Exploring Alternate Payload in SOD1-ALS Gene Therapy Program
New three-month data from a study of nonhuman primates underpins the biotech firm's decision to amend the small interfering RNA program.
Galapagos Partners With NecstGen to Support Decentralized Cell Therapy Manufacturing
The firm will use NecstGen's cleanroom infrastructure to support manufacturing of its CAR T-cell therapies.
Ibex AI-Driven Prostate Cancer Screening Test Nets FDA Clearance
Ibex Prostate Detect is designed to help pathologists catch small and rare cancers in whole-slide images from tissue biopsies that they might've missed.
Mustang Bio Closes $8M Public Offering
The biopharma company, which is developing cell therapies for cancers and autoimmune diseases, said it will use the proceeds for working capital.
Immuneering Partners with Regeneron to Study Combined MEK, PD-1 Inhibitor Therapy in Solid Tumors
Regeneron will supply Libtayo within an ongoing Phase II trial of Immuneering's MEK inhibitor.
Maze Therapeutics Doses First Patient in Phase II APOL1 Inhibitor Kidney Disease Trial
Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
In Brief This Week: Ocugen, Acrivon, Myriad Genetics, Ariceum, Arbor Biotechnologies
News items for the week of Feb. 3, 2025.
Genomenon, Mirum Pharmaceuticals Partner for Rare Disease Data Sharing
Mirum has tapped Genomenon to produce a "landscape" of CYP27A1 gene variants to improve awareness and diagnosis of cerebrotendinous xanthomatosis.